ACTIVE LAWSUIT!

SEE IF YOU QUALIFY

Belviq Lawsuit | 2025 Latest Updates

Belviq (generic: lorcaserin), a popular weight-loss drug made by Eisai Inc., was recalled by the U.S. Food and Drug Administration (FDA) in February 2020 after studies found an increased risk of cancer associated with the medication. People who want to lose weight safely may be looking for alternatives to Belviq in order to avoid the cancer risk.
Award Logos
C.L. Mike Schmidt Published by C.L. Mike Schmidt

Free Confidential Belviq Lawsuit Review
If you or a loved one developed cancer following the use of Belviq (lorcaserin), you may be entitled to pursue compensation.

At Schmidt&Clark, we are dedicated to helping individuals who have suffered due to dangerous pharmaceuticals. Our experienced legal team is here to guide you through the process and fight for the compensation you deserve.

Contact Schmidt&Clark today for a free, no-obligation consultation.

Start My Free Case Review

Belviq Lawsuit Overview

Belviq lawsuits involve claims against Eisai Inc. for their weight-loss drug that was recalled by the FDA in February 2020. The primary allegations center on the increased risk of cancer associated with the medication. Thousands of patients who took Belviq for weight management are now pursuing legal action after developing various types of cancer. The FDA issued a full market withdrawal after studies confirmed the cancer risk.

Related Article: Belviq Lawsuit Update

Latest Belviq Lawsuit Updates

March 8, 2025 –  Individuals diagnosed with pancreatic, colorectal, or lung cancer after taking Belviq are pursuing legal claims against Eisai Inc. The lawsuits allege that the manufacturer failed to disclose cancer risks associated with the drug. As legal proceedings continue, affected individuals are encouraged to seek compensation for medical expenses and damages [1].

February 2020 – The FDA issued a full recall of Belviq after clinical studies found an increased cancer risk among users, prompting the removal of all Belviq products from the U.S. market

Related Article: What Types of Cancer Are Linked to Belviq?

FDA Reports and Statistics

The FDA’s decision to recall Belviq was based on the CAMELLIA-TIMI 61 safety clinical trial, which showed an increased occurrence of cancer among Belviq users. The study revealed that 7.7% of Belviq users (462 out of 6,000) developed cancer compared to 7.1% in the placebo group (423 out of 6,000), with notable increases in pancreatic, colorectal, and lung cancers driving the overall risk.

Belviq Injuries & Side Effects

Belviq use has been associated with various serious health conditions, primarily cancer:

  • Cancer Development: Pancreatic, colorectal, and lung cancer
  • Cardiovascular Issues: Heart valve problems and arrhythmia
  • Neurological Effects: Headaches, dizziness, and fatigue
  • Psychiatric Symptoms: Depression and suicidal thoughts

Do You Qualify for a Belviq Lawsuit?

You may qualify for a Belviq lawsuit if:

  • You used Belviq or Belviq XR for weight loss
  • You were diagnosed with cancer after taking the medication
  • Your cancer diagnosis occurred within a reasonable time after Belviq use
  • You can provide medical documentation linking your cancer to Belviq use

Evidence Required for a Belviq Lawsuit

To strengthen your Belviq lawsuit, you should gather:

  • Medical records documenting your Belviq prescription
  • Proof of Belviq purchase (pharmacy records, receipts)
  • Medical records of your cancer diagnosis
  • Documentation of all treatments and medical expenses

Damages You Can Recover

A successful Belviq lawsuit may provide compensation for:

  • Medical expenses for cancer treatment
  • Lost wages and diminished earning capacity
  • Pain and suffering related to your diagnosis and treatment
  • Punitive damages against the manufacturer

Related ArticleWhy Was Belviq Taken Off the Market?

Belviq Recall Information

On February 13, 2020, the FDA requested a voluntary withdrawal of Belviq from the U.S. market, which Eisai Inc. implemented. This recall affected:

  • Belviq tablets (10 mg)
  • Belviq XR extended-release tablets (20 mg)
    No generic lorcaserin products were included, as none were approved for sale in the U.S. at the time of the recall.

Statute of Limitations for Belviq Lawsuits

The time limit to file a Belviq lawsuit varies by state but typically ranges from 1-3 years from when you discovered or should have discovered your cancer was linked to Belviq use. Given the 2020 recall, many potential claimants still have time to file, but this window is closing in some states.

FAQs

1. What is Belviq and why was it recalled?

Belviq (lorcaserin) was a weight-loss medication recalled by the FDA in February 2020 after studies found an increased risk of cancer among users.

2. What types of cancer are linked to Belviq?

Pancreatic, colorectal, and lung cancers have been most strongly linked to Belviq use in clinical studies.

3. What alternatives can I use instead of Belviq?

Safer prescription alternatives include Contrave (naltrexone and bupropion), Saxenda (liraglutide), and Qsymia, each with different mechanisms and risk profiles.

4. How is Contrave different from Belviq?

While both treat obesity, Belviq is a serotonin 2C receptor agonist, whereas Contrave combines an opioid antagonist and an antidepressant, with a different side effect profile.

5. Is Belviq similar to Phentermine?

No, Phentermine works differently by stimulating the central nervous system like amphetamine to reduce appetite, while Belviq affects serotonin receptors.

6. How effective are surgical weight loss options?

Surgical options like gastric bypass and sleeve gastrectomy can produce significant weight loss and improve obesity-related conditions in appropriate candidates.

7. What lifestyle changes can help with weight loss?

Effective lifestyle approaches include a balanced diet, regular exercise, behavioral therapy, and support groups for sustainable weight management.

8. Are there non-prescription options for weight loss?

Yes, options include dietary supplements, meal replacement programs, and over-the-counter weight loss aids, though efficacy varies.

9. How do I know if I qualify for a Belviq lawsuit?

You likely qualify if you took Belviq and subsequently developed cancer, especially pancreatic, colorectal, or lung cancer.

10. What is the average settlement amount for Belviq lawsuits?

Settlement amounts vary based on cancer severity, treatment costs, and other damages, with cases still being litigated nationwide.

Related Article:

See all related dangerous drug litigations our lawyers have covered.

Time is limited to pursue legal action for Belviq-related cancer claims. Most states only allow 1-3 years from the date of diagnosis or discovery of the connection between Belviq and your cancer.

The Pharmaceutical Litigation Group at Schmidt & Clark, LLP offers:

  • Free, confidential consultations
  • No upfront costs or fees
  • Payment only if we win your case

If you or a loved one developed cancer after taking Belviq, contact our law firm immediately. You may be entitled to significant compensation, and we can help.

[START YOUR FREE CASE REVIEW NOW]

Reference:

[1] https://www.drugwatch.com/belviq/lawsuits/ 

Get a Free Case Review

You may be entitled to financial compensation.
Secure Submission